Grafting the iPSC-derived endothelial cells with the FVIII mutation corrected by CRISPR/Cas9 into the hemophilia mouse models indeed leads to a hemostatic effect, and with robust, optimized differentiation/purification protocols, engrafted cells can survive for months [243]. This evidence concerns the gene F8 and hemophilia.